Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy

BACKGROUND: Periprocedural pulmonary vein isolation (PVI) anticoagulation requires balancing between bleeding and thromboembolic risk. Intraprocedural anticoagulation is monitored by activated clotting time (ACT) with target value >300 s, and there are no guidelines specifying an initial unfracti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeljkovic, Ivan, Brusich, Sandro, Scherr, Daniel, Velagic, Vedran, Traykov, Vassil, Pernat, Andrej, Anic, Ante, Szavits Nossan, Janko, Jan, Matevz, Bakotic, Zoran, Pezo Nikolic, Borka, Radeljic, Vjekoslav, Bojko, Ana, Benko, Ivica, Manola, Sime, Pavlovic, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364723/
https://www.ncbi.nlm.nih.gov/pubmed/34196416
http://dx.doi.org/10.1002/clc.23681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364723/
https://www.ncbi.nlm.nih.gov/pubmed/34196416
http://dx.doi.org/10.1002/clc.23681

Ejemplares similares